Caris Life Sciences also found that time-to-next treatment could be a surrogate endpoint for survival.
A genetic testing utilization service launched by Stanford in 2015 helped cut the number of inappropriately ordered tests in half and saved about $250,000 during the first year.
Clinicians in the hospital will use IBM's Watson to identify possible options for diagnosing and treating rare pediatric diseases starting with kidney disease.
Most study participants seem to be increasingly comfortable contributing their genetic results to their electronic medical records as the study progresses.
Use of the blood culture panel in a community hospital setting led to shorter time to targeted treatment for the patient and a shorter stay in the hospital.
The collaboration will explore the clinical utility of Trovagene's platform for detecting and monitoring EGFR mutations in lung cancer patients.
Originally published Oct. 12.
Originally published May 4.
Nature News reports that gene therapy approaches are tackling sickle cell disease, but that the cost of treatment is a concern.
The Washington Post reports that a US Senate committee voted this week to approve the nomination of Stephen Hahn to lead the Food and Drug Administration.
One gene regulates hundreds of others to influence facial development, according to New Scientist.
In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.